Integra Lifesciences Holdings (IART) Assets Average (2010 - 2026)

Integra Lifesciences Holdings (IART) has 17 years of Assets Average data on file, last reported at $3.6 billion in Q1 2026.

• For the quarter ending Q1 2026, Assets Average fell 11.25% year-over-year to $3.6 billion; the trailing twelve-month figure through Mar 2026 stood at $3.6 billion (down 11.25% YoY), and the FY2025 full-year result was $3.8 billion, down 2.3% from the prior year.
• Assets Average slipped to $3.6 billion in Q1 2026, from $3.6 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $4.1 billion in Q2 2024 to a low of $3.6 billion in Q1 2026.
• A 5-year average of $3.8 billion and a median of $3.8 billion in 2022 frame the typical range for Assets Average.
• Across the five-year window, Assets Average grew 8.41% in 2024 and decreased 11.25% in 2026, its largest moves.
• Tracing IART's Assets Average over 5 years: stood at $3.8 billion in 2022, then slipped by 2.28% to $3.8 billion in 2023, then climbed by 7.74% to $4.1 billion in 2024, then retreated by 10.55% to $3.6 billion in 2025, then declined by 0.95% to $3.6 billion in 2026.
• Business Quant data shows IART's Assets Average at $3.6 billion in Q1 2026, $3.6 billion in Q4 2025, and $3.7 billion in Q3 2025.